{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:33:29Z","timestamp":1784712809925,"version":"3.55.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["No. 2022M721981"],"award-info":[{"award-number":["No. 2022M721981"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["No.ZR2020QH094"],"award-info":[{"award-number":["No.ZR2020QH094"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["No.82000195"],"award-info":[{"award-number":["No.82000195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["No.82270200,  No.82070203 and No.81770210"],"award-info":[{"award-number":["No.82270200,  No.82070203 and No.81770210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taishan Scholars Program of Shandong Province","award":["No.tsqn201909184"],"award-info":[{"award-number":["No.tsqn201909184"]}]},{"name":"Taishan Scholars Program of Shandong Province","award":["No.tsqn201909184"],"award-info":[{"award-number":["No.tsqn201909184"]}]},{"DOI":"10.13039\/100014103","name":"Key Research and Development Program of Shandong Province","doi-asserted-by":"crossref","award":["No.2018CXGC1213"],"award-info":[{"award-number":["No.2018CXGC1213"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Translational Research Grant of NCRCH","award":["No.2021WWB02, No.2020ZKMB01"],"award-info":[{"award-number":["No.2021WWB02, No.2020ZKMB01"]}]},{"name":"Shandong Provincial Engineering Research Center of Lymphoma"},{"name":"Academic Promotion Programme of Shandong First Medical University","award":["No.2019QL018"],"award-info":[{"award-number":["No.2019QL018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with alterations in genetic expression and epigenetic modifications. In recent years, the new insight into epigenetics in the pathogenesis of CLL has been developed considerably, including DNA methylation, histone modification, RNA methylation, non-coding RNAs as well as chromatin remodeling. Epigenetic modification regulates various processes such as stem cell biology, cell growth, and tumorigenesis without altering gene sequence. Growing evidence indicates that the disturbance of gene expression profiles which were regulated by epigenetic modifications exerts vital roles in the development and progress in CLL, which provides novel perspectives to explore the etiology of CLL. In addition, the integration with epigenetic therapeutic targets and the in-depth understanding of epigenetic therapy contribute to develop new therapeutic strategies for CLL. Herein, the present review discusses the advances of epigenetic alterations in the pathogenesis, diagnosis, and prognostic assessment of CLL patients and also highlights existing and emerging agents targeting epigenetic regulators.<\/jats:p>","DOI":"10.1007\/s10238-023-01268-x","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T12:01:33Z","timestamp":1710590493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment"],"prefix":"10.1007","volume":"24","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,16]]},"reference":[{"issue":"5","key":"1268_CR1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJMra1908213","volume":"383","author":"JA Burger","year":"2020","unstructured":"Burger JA. Treatment of chronic lymphocytic leukemia. N Engl J Med. 2020;383(5):460\u201373.","journal-title":"N Engl J Med"},{"issue":"21","key":"1268_CR2","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1001\/jama.2014.14553","volume":"312","author":"C Nabhan","year":"2014","unstructured":"Nabhan C, Rosen ST. Chronic lymphocytic leukemia: a clinical review. JAMA. 2014;312(21):2265\u201376.","journal-title":"JAMA"},{"issue":"10","key":"1268_CR3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood.2020010029","volume":"138","author":"FK Stevenson","year":"2021","unstructured":"Stevenson FK, Forconi F, Kipps TJ. Exploring the pathways to chronic lymphocytic leukemia. Blood. 2021;138(10):827\u201335.","journal-title":"Blood"},{"issue":"9617","key":"1268_CR4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(08)60456-0","volume":"371","author":"G Dighiero","year":"2008","unstructured":"Dighiero G, Hamblin TJ. Chronic lymphocytic leukaemia. The Lancet. 2008;371(9617):1017\u201329.","journal-title":"The Lancet"},{"issue":"8","key":"1268_CR5","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27765","volume":"66","author":"L Jones","year":"2019","unstructured":"Jones L, McCalmont H, Evans K, Mayoh C, Kurmasheva RT, Billups CA, Houghton PJ, Smith MA, Lock RB. Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts. Pediatr Blood Cancer. 2019;66(8): e27765.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1268_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12\u201327.","journal-title":"Cell"},{"issue":"1","key":"1268_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc2765","volume":"10","author":"J Chen","year":"2010","unstructured":"Chen J, Odenike O, Rowley JD. Leukaemogenesis: more than mutant genes. Nat Rev Cancer. 2010;10(1):23\u201336.","journal-title":"Nat Rev Cancer"},{"key":"1268_CR8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3389\/fonc.2019.00850","volume":"9","author":"B Wingelhofer","year":"2019","unstructured":"Wingelhofer B, Somervaille TCP. Emerging epigenetic therapeutic targets in acute myeloid leukemia. Front Oncol. 2019;9:850.","journal-title":"Front Oncol"},{"key":"1268_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2019.05.013","volume":"140","author":"V Santini","year":"2019","unstructured":"Santini V, Ossenkoppele GJ. Hypomethylating agents in the treatment of acute myeloid leukemia: a guide to optimal use. Crit Rev Oncol Hematol. 2019;140:1\u20137.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"1268_CR10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg1655","volume":"6","author":"KD Robertson","year":"2005","unstructured":"Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005;6(8):597\u2013610.","journal-title":"Nat Rev Genet"},{"issue":"25","key":"1268_CR11","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1021\/bi200642e","volume":"50","author":"J Li","year":"2011","unstructured":"Li J, Poi MJ, Tsai MD. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry. 2011;50(25):5566\u201382.","journal-title":"Biochemistry"},{"issue":"12","key":"1268_CR12","first-page":"3782","volume":"8","author":"A Bearzatto","year":"2002","unstructured":"Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Clin Cancer Res. 2002;8(12):3782\u20137.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1268_CR13","first-page":"3225","volume":"61","author":"M Esteller","year":"2001","unstructured":"Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res. 2001;61(8):3225\u20139.","journal-title":"Cancer Res"},{"issue":"9","key":"1268_CR14","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/cncr.21409","volume":"104","author":"JS Kim","year":"2005","unstructured":"Kim JS, Han J, Shim YM, Park J, Kim DH. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma. Cancer. 2005;104(9):1825\u201333.","journal-title":"Cancer"},{"issue":"11","key":"1268_CR15","first-page":"4556","volume":"61","author":"KO Toyooka","year":"2001","unstructured":"Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res. 2001;61(11):4556\u201360.","journal-title":"Cancer Res"},{"issue":"3","key":"1268_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.onc.1204104","volume":"20","author":"AS Fleisher","year":"2001","unstructured":"Fleisher AS, Esteller M, Tamura G, Rashid A, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Nishizuka S, et al. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene. 2001;20(3):329\u201335.","journal-title":"Oncogene"},{"issue":"15","key":"1268_CR17","first-page":"3455","volume":"58","author":"JM Cunningham","year":"1998","unstructured":"Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998;58(15):3455\u201360.","journal-title":"Cancer Res"},{"issue":"9","key":"1268_CR18","doi-asserted-by":"crossref","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","volume":"8","author":"SB Baylin","year":"2016","unstructured":"Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016;8(9):a019505.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1268_CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13148-017-0356-0","volume":"9","author":"L Rani","year":"2017","unstructured":"Rani L, Mathur N, Gupta R, Gogia A, Kaur G, Dhanjal JK, Sundar D, Kumar L, Sharma A. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia. Clin Epigenetics. 2017;9:57.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"1268_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2217\/epi.09.10","volume":"1","author":"FB Rahmatpanah","year":"2009","unstructured":"Rahmatpanah FB, Carstens S, Hooshmand SI, Welsh EC, Sjahputera O, Taylor KH, Bennett LB, Shi H, Davis JW, Arthur GL, et al. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics. 2009;1(1):39\u201361.","journal-title":"Epigenomics"},{"key":"1268_CR21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13148-016-0274-6","volume":"8","author":"S Subhash","year":"2016","unstructured":"Subhash S, Andersson PO, Kosalai ST, Kanduri C, Kanduri M. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL. Clin Epigenetics. 2016;8:106.","journal-title":"Clin Epigenetics"},{"key":"1268_CR22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13148-017-0422-7","volume":"9","author":"C Bagacean","year":"2017","unstructured":"Bagacean C, Le Dantec C, Berthou C, Tempescul A, Saad H, Bordron A, Zdrenghea M, Cristea V, Douet-Guilbert N, Renaudineau Y. Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion. Clin Epigenetics. 2017;9:122.","journal-title":"Clin Epigenetics"},{"key":"1268_CR23","doi-asserted-by":"crossref","first-page":"1056043","DOI":"10.3389\/fgene.2022.1056043","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Gao Y, Lin S, Goldin LR, Wang Y, Stevenson H, Edelman DC, Killian K, Marti G, Meltzer PS, et al. Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia. Front Genet. 2022;13:1056043.","journal-title":"Front Genet"},{"issue":"1","key":"1268_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","volume":"44","author":"V Quesada","year":"2011","unstructured":"Quesada V, Conde L, Villamor N, Ord\u00f3\u00f1ez GR, Jares P, Bassaganyas L, Ramsay AJ, Be\u00e0 S, Pinyol M, Mart\u00ednez-Trillos A, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet. 2011;44(1):47\u201352.","journal-title":"Nat Genet"},{"issue":"17","key":"1268_CR25","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.3390\/ijms22179337","volume":"22","author":"A Pacholewska","year":"2021","unstructured":"Pacholewska A, Grimm C, Herling CD, Lienhard M, K\u00f6nigs A, Timmermann B, Altm\u00fcller J, M\u00fccke O, Reinhardt HC, Plass C, et al. Altered DNA methylation profiles in SF3B1 mutated CLL patients. Int J Mol Sci. 2021;22(17):9337.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1268_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1268_CR27","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1158\/1541-7786.MCR-20-0933","volume":"19","author":"H Li","year":"2021","unstructured":"Li H, Zhao J, Sun J, Tian C, Jiang Q, Ding C, Gan Q, Shu P, Wang X, Qin J, et al. Demethylation of the SFRP4 promoter drives gastric cancer progression via the Wnt pathway. Molecul cancer res MCR. 2021;19(9):1454\u201364.","journal-title":"Molecul cancer res MCR"},{"key":"1268_CR28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cellsig.2018.01.019","volume":"45","author":"NM Pawar","year":"2018","unstructured":"Pawar NM, Rao P. Secreted frizzled related protein 4 (sFRP4) update: a brief review. Cell Signal. 2018;45:63\u201370.","journal-title":"Cell Signal"},{"issue":"2","key":"1268_CR29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/0008-5472.CAN-05-3712","volume":"66","author":"TH Liu","year":"2006","unstructured":"Liu TH, Raval A, Chen SS, Matkovic JJ, Byrd JC, Plass C. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res. 2006;66(2):653\u20138.","journal-title":"Cancer Res"},{"issue":"6","key":"1268_CR30","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4161\/epi.28603","volume":"9","author":"S Deneberg","year":"2014","unstructured":"Deneberg S, Kanduri M, Ali D, Bengtzen S, Karimi M, Qu Y, Kimby E, Mansouri L, Rosenquist R, Lennartsson A, et al. microRNA-34b\/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia. Epigenetics. 2014;9(6):910\u20137.","journal-title":"Epigenetics"},{"issue":"17","key":"1268_CR31","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2005.02.196","volume":"23","author":"A Raval","year":"2005","unstructured":"Raval A, Lucas DM, Matkovic JJ, Bennett KL, Liyanarachchi S, Young DC, Rassenti L, Kipps TJ, Grever MR, Byrd JC, et al. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. J Clin Oncol. 2005;23(17):3877\u201385.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1268_CR32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/sj.leu.2404220","volume":"20","author":"M Bilban","year":"2006","unstructured":"Bilban M, Heintel D, Scharl T, Woelfel T, Auer MM, Porpaczy E, Kainz B, Krober A, Carey VJ, Shehata M, et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia. 2006;20(6):1080\u20138.","journal-title":"Leukemia"},{"issue":"8","key":"1268_CR33","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3324\/haematol.2010.039396","volume":"96","author":"MA Kaderi","year":"2011","unstructured":"Kaderi MA, Kanduri M, Buhl AM, Sevov M, Cahill N, Gunnarsson R, Jansson M, Smedby KE, Hjalgrim H, Jurlander J, et al. LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia. Haematologica. 2011;96(8):1153\u201360.","journal-title":"Haematologica"},{"issue":"8","key":"1268_CR34","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3109\/10428194.2013.796057","volume":"54","author":"C Abreu","year":"2013","unstructured":"Abreu C, Moreno P, Palacios F, Borge M, Morande P, Landoni AI, Gabus R, Dighiero G, Giordano M, Gamberale R, et al. Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia. Leuk Lymphoma. 2013;54(8):1844\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"1268_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrg.2017.80","volume":"19","author":"F Lyko","year":"2018","unstructured":"Lyko F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat Rev Genet. 2018;19(2):81\u201392.","journal-title":"Nat Rev Genet"},{"issue":"24","key":"1268_CR36","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1158\/0008-5472.CAN-21-1273","volume":"81","author":"A Biran","year":"2021","unstructured":"Biran A, Yin S, Kretzmer H, Ten Hacken E, Parvin S, Lucas F, Uduman M, Gutierrez C, Dangle N, Billington L, et al. Activation of notch and myc signaling via B-cell-restricted depletion of dnmt3a generates a consistent murine model of chronic lymphocytic leukemia. Cancer Res. 2021;81(24):6117\u201330.","journal-title":"Cancer Res"},{"issue":"11","key":"1268_CR37","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/ijc.31999","volume":"144","author":"N Papakonstantinou","year":"2019","unstructured":"Papakonstantinou N, Ntoufa S, Tsagiopoulou M, Moysiadis T, Bhoi S, Malousi A, Psomopoulos F, Mansouri L, Laidou S, Papazoglou D, et al. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia. Int J Cancer. 2019;144(11):2695\u2013706.","journal-title":"Int J Cancer"},{"issue":"2","key":"1268_CR38","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41416-020-01117-8","volume":"124","author":"TM Barrow","year":"2021","unstructured":"Barrow TM, Nakjang S, Lafta F, Bilotkach K, Woodhouse L, Junge G, Tudhope SJ, Wallis JP, Marr H, Marshall S, et al. Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia. Br J Cancer. 2021;124(2):474\u201383.","journal-title":"Br J Cancer"},{"issue":"11","key":"1268_CR39","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","volume":"44","author":"M Kulis","year":"2012","unstructured":"Kulis M, Heath S, Bibikova M, Queiros AC, Navarro A, Clot G, Martinez-Trillos A, Castellano G, Brun-Heath I, Pinyol M, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet. 2012;44(11):1236\u201342.","journal-title":"Nat Genet"},{"issue":"1","key":"1268_CR40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13148-019-0783-1","volume":"11","author":"M Tsagiopoulou","year":"2019","unstructured":"Tsagiopoulou M, Papakonstantinou N, Moysiadis T, Mansouri L, Ljungstrom V, Duran-Ferrer M, Malousi A, Queiros AC, Plevova K, Bhoi S, et al. DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy. Clin Epigenetics. 2019;11(1):177.","journal-title":"Clin Epigenetics"},{"issue":"4","key":"1268_CR41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693\u2013705.","journal-title":"Cell"},{"issue":"6","key":"1268_CR42","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0955-0674(93)90080-A","volume":"5","author":"S Clarke","year":"1993","unstructured":"Clarke S. Protein methylation. Curr Opin Cell Biol. 1993;5(6):977\u201383.","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"1268_CR43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381\u201395.","journal-title":"Cell Res"},{"key":"1268_CR44","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2147\/OTT.S121301","volume":"10","author":"K Zhou","year":"2017","unstructured":"Zhou K, Zhang Q, Liu Y, Xiong Y, Wu S, Yang J, Zhou H, Liu X, Wei X, Song Y. Aberrant histone modification in CD19(+) B cells of patients with chronic lymphocytic leukemia. Onco Targets Ther. 2017;10:1173\u20139.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"1268_CR45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semcdb.2009.10.007","volume":"21","author":"M Albert","year":"2010","unstructured":"Albert M, Helin K. Histone methyltransferases in cancer. Semin Cell Dev Biol. 2010;21(2):209\u201320.","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"1268_CR46","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11(10):726\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"7279","key":"1268_CR47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","volume":"463","author":"GL Dalgliesh","year":"2010","unstructured":"Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, Davies H, Edkins S, Hardy C, Latimer C, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature. 2010;463(7279):360\u20133.","journal-title":"Nature"},{"issue":"6","key":"1268_CR48","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.celrep.2014.05.026","volume":"7","author":"SX Pfister","year":"2014","unstructured":"Pfister SX, Ahrabi S, Zalmas LP, Sarkar S, Aymard F, Bachrati CZ, Helleday T, Legube G, La Thangue NB, Porter AC, et al. SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability. Cell Rep. 2014;7(6):2006\u201318.","journal-title":"Cell Rep"},{"key":"1268_CR49","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02482","volume":"3","author":"S Carvalho","year":"2014","unstructured":"Carvalho S, Vitor AC, Sridhara SC, Martins FB, Raposo AC, Desterro JM, Ferreira J, de Almeida SF. SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint. Elife. 2014;3: e02482.","journal-title":"Elife"},{"issue":"11","key":"1268_CR50","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/leu.2016.134","volume":"30","author":"H Parker","year":"2016","unstructured":"Parker H, Rose-Zerilli MJ, Larrayoz M, Clifford R, Edelmann J, Blakemore S, Gibson J, Wang J, Ljungstrom V, Wojdacz TK, et al. Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia. Leukemia. 2016;30(11):2179\u201386.","journal-title":"Leukemia"},{"issue":"14","key":"1268_CR51","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.4161\/cc.9.14.12323","volume":"9","author":"P Yaswen","year":"2010","unstructured":"Yaswen P. HDAC inhibitors conquer Polycomb proteins. Cell Cycle. 2010;9(14):2705.","journal-title":"Cell Cycle"},{"issue":"1","key":"1268_CR52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcmd.2014.07.013","volume":"54","author":"A Rabello Ddo","year":"2015","unstructured":"Rabello Ddo A, Lucena-Araujo AR, Alves-Silva JC, da Eira VB, de Vasconcellos MC, de Oliveira FM, Rego EM, Saldanha-Araujo F, Pittella Silva F. Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia. Blood Cells Mol Dis. 2015;54(1):97\u2013102.","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"1268_CR53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yexmp.2018.07.009","volume":"105","author":"K Szurian","year":"2018","unstructured":"Szurian K, Csala I, Marosvari D, Rajnai H, Dezso K, Bodor C, Piurko V, Matolcsy A, Reiniger L. EZH2 is upregulated in the proliferation centers of CLL\/SLL lymph nodes. Exp Mol Pathol. 2018;105(2):161\u20135.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"1268_CR54","first-page":"44","volume":"142","author":"Q Jiang","year":"2023","unstructured":"Jiang Q, Stachelscheid J, Bloehdorn J, Pacholewska A, Aszyk CM, Grotenhuijs F, M\u00fcller TA, Onder O, Wagle P, Herling CD, et al. Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia. Blood. 2023;142(1):44\u201361.","journal-title":"Blood"},{"key":"1268_CR55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2407-13-88","volume":"13","author":"G Jordaan","year":"2013","unstructured":"Jordaan G, Liao W, Sharma S. E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors. BMC Cancer. 2013;13:88.","journal-title":"BMC Cancer"},{"issue":"10","key":"1268_CR56","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1268_CR57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, Adhikari S, Shi Y, Lv Y, Chen YS, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177\u201389.","journal-title":"Cell Res"},{"issue":"5","key":"1268_CR58","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","volume":"169","author":"KE Pendleton","year":"2017","unstructured":"Pendleton KE, Chen B, Liu K, Hunter OV, Xie Y, Tu BP, Conrad NK. The U6 snRNA m(6)A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell. 2017;169(5):824-835.e814.","journal-title":"Cell"},{"key":"1268_CR59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","volume":"33","author":"KD Meyer","year":"2017","unstructured":"Meyer KD, Jaffrey SR. Rethinking m(6)A readers, writers, and erasers. Annu Rev Cell Dev Biol. 2017;33:319\u201342.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"1268_CR60","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18(1):176.","journal-title":"Mol Cancer"},{"issue":"3","key":"1268_CR61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m(6)A Modification in Coding and Non-coding RNAs: roles and Therapeutic Implications in Cancer. Cancer Cell. 2020;37(3):270\u201388.","journal-title":"Cancer Cell"},{"issue":"1","key":"1268_CR62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, Huang H, Nachtergaele S, Dong L, Hu C, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-Methyladenosine RNA Demethylase. Cancer Cell. 2017;31(1):127\u201341.","journal-title":"Cancer Cell"},{"issue":"1","key":"1268_CR63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00432-018-2796-0","volume":"145","author":"J Chen","year":"2019","unstructured":"Chen J, Du B. Novel positioning from obesity to cancer: FTO, an m(6)A RNA demethylase, regulates tumour progression. J Cancer Res Clin Oncol. 2019;145(1):19\u201329.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"Supplement 1","key":"1268_CR64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood-2020-139526","volume":"136","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Hu X, Han Y, Zhou X, Zhang H, Yun X, Wang X. Targeting inhibition of n6-methyladenosine demethylase fto displays potent anti-tumor activities in chronic lymphocytic leukemia. Blood. 2020;136(Supplement 1):35\u20136.","journal-title":"Blood"},{"issue":"4","key":"1268_CR65","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1268_CR66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/cdd.2014.87","volume":"22","author":"Y Pekarsky","year":"2015","unstructured":"Pekarsky Y, Croce CM. Role of miR-15\/16 in CLL. Cell Death Differ. 2015;22(1):6\u201311.","journal-title":"Cell Death Differ"},{"issue":"39","key":"1268_CR67","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 2005;102(39):13944\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1268_CR68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/cdd.2017.159","volume":"25","author":"Y Pekarsky","year":"2018","unstructured":"Pekarsky Y, Balatti V, Croce CM. BCL2 and miR-15\/16: from gene discovery to treatment. Cell Death Differ. 2018;25(1):21\u20136.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1268_CR69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.2010.1919","volume":"305","author":"M Fabbri","year":"2011","unstructured":"Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, et al. Association of a microRNA\/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA. 2011;305(1):59\u201367.","journal-title":"JAMA"},{"issue":"3","key":"1268_CR70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cytogfr.2011.05.002","volume":"22","author":"RX Leng","year":"2011","unstructured":"Leng RX, Pan HF, Qin WZ, Chen GM, Ye DQ. Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev. 2011;22(3):141\u20137.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"1268_CR71","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2014-03-559690","volume":"124","author":"B Cui","year":"2014","unstructured":"Cui B, Chen L, Zhang S, Mraz M, Fecteau JF, Yu J, Ghia EM, Zhang L, Bao L, Rassenti LZ, et al. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood. 2014;124(4):546\u201354.","journal-title":"Blood"},{"issue":"11","key":"1268_CR72","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","volume":"122","author":"A Ferrajoli","year":"2013","unstructured":"Ferrajoli A, Shanafelt TD, Ivan C, Shimizu M, Rabe KG, Nouraee N, Ikuo M, Ghosh AK, Lerner S, Rassenti LZ, et al. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013;122(11):1891\u20139.","journal-title":"Blood"},{"issue":"5","key":"1268_CR73","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood.2018882290","volume":"134","author":"CL Chiang","year":"2019","unstructured":"Chiang CL, Goswami S, Frissora FW, Xie Z, Yan PS, Bundschuh R, Walker LA, Huang X, Mani R, Mo XM, et al. ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model. Blood. 2019;134(5):432\u201344.","journal-title":"Blood"},{"issue":"18","key":"1268_CR74","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood.2020005627","volume":"137","author":"S Sharma","year":"2021","unstructured":"Sharma S, Pavlasova GM, Seda V, Cerna KA, Vojackova E, Filip D, Ondrisova L, Sandova V, Kostalova L, Zeni PF, et al. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors. Blood. 2021;137(18):2481\u201394.","journal-title":"Blood"},{"issue":"20","key":"1268_CR75","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/blood-2018-04-845115","volume":"132","author":"V Balatti","year":"2018","unstructured":"Balatti V, Tomasello L, Rassenti LZ, Veneziano D, Nigita G, Wang HY, Thorson JA, Kipps TJ, Pekarsky Y, Croce CM. miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients. Blood. 2018;132(20):2179\u201382.","journal-title":"Blood"},{"issue":"1","key":"1268_CR76","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood-2013-09-527234","volume":"124","author":"M Mraz","year":"2014","unstructured":"Mraz M, Chen L, Rassenti LZ, Ghia EM, Li H, Jepsen K, Smith EN, Messer K, Frazer KA, Kipps TJ. miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood. 2014;124(1):84\u201395.","journal-title":"Blood"},{"issue":"9","key":"1268_CR77","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1182\/blood-2014-12-618025","volume":"126","author":"J Paggetti","year":"2015","unstructured":"Paggetti J, Haderk F, Seiffert M, Janji B, Distler U, Ammerlaan W, Kim YJ, Adam J, Lichter P, Solary E, et al. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood. 2015;126(9):1106\u201317.","journal-title":"Blood"},{"issue":"1","key":"1268_CR78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47\u201362.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"1268_CR79","doi-asserted-by":"crossref","first-page":"e1003373","DOI":"10.1371\/journal.pgen.1003373","volume":"9","author":"A Garding","year":"2013","unstructured":"Garding A, Bhattacharya N, Claus R, Ruppel M, Tschuch C, Filarsky K, Idler I, Zucknick M, Caudron-Herger M, Oakes C, et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. PLoS Genet. 2013;9(4):e1003373.","journal-title":"PLoS Genet"},{"issue":"6","key":"1268_CR80","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.semcancer.2010.09.003","volume":"20","author":"Y Pekarsky","year":"2010","unstructured":"Pekarsky Y, Zanesi N, Croce CM. Molecular basis of CLL. Semin Cancer Biol. 2010;20(6):370\u20136.","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"1268_CR81","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.3390\/ijms19092475","volume":"19","author":"M Dahl","year":"2018","unstructured":"Dahl M, Kristensen LS, Gronbaek K. Long non-coding RNAs guide the fine-tuning of gene regulation in B-cell development and malignancy. Int J Mol Sci. 2018;19(9):2475.","journal-title":"Int J Mol Sci"},{"key":"1268_CR82","volume":"105","author":"J Ni","year":"2021","unstructured":"Ni J, Hong J, Li Q, Zeng Q, Xia R. Long non-coding RNA CRNDE suppressing cell proliferation is regulated by DNA methylation in chronic lymphocytic leukemia. Leuk Res. 2021;105: 106564.","journal-title":"Leuk Res"},{"key":"1268_CR83","volume":"110","author":"X Du","year":"2021","unstructured":"Du X, Liu H, Yang C, Shi X, Cao L, Zhao X, Miao Y, Zhu H, Wang L, Xu W, et al. LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia. Leuk Res. 2021;110: 106706.","journal-title":"Leuk Res"},{"issue":"6","key":"1268_CR84","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/bjh.15237","volume":"184","author":"R Bomben","year":"2019","unstructured":"Bomben R, Roisman A, D\u2019Agaro T, Castellano G, Baumann T, Delgado J, L\u00f3pez-Guillermo A, Zucchetto A, Dal-Bo M, Bravin V, et al. Expression of the transcribed ultraconserved region 70 and the related long non-coding RNA AC092652.2\u2013202 has prognostic value in chronic lymphocytic leukaemia. Br J Haematol. 2019;184(6):1045\u201350.","journal-title":"Br J Haematol"},{"issue":"9","key":"1268_CR85","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.77","volume":"6","author":"D Ronchetti","year":"2016","unstructured":"Ronchetti D, Manzoni M, Agnelli L, Vinci C, Fabris S, Cutrona G, Matis S, Colombo M, Galletti S, Taiana E, et al. lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome. Blood Cancer J. 2016;6(9): e468.","journal-title":"Blood Cancer J"},{"key":"1268_CR86","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cca.2014.02.010","volume":"431","author":"M Isin","year":"2014","unstructured":"Isin M, Ozgur E, Cetin G, Erten N, Aktan M, Gezer U, Dalay N. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta. 2014;431:255\u20139.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"1268_CR87","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/leu.2015.119","volume":"29","author":"CJ Blume","year":"2015","unstructured":"Blume CJ, Hotz-Wagenblatt A, H\u00fcllein J, Sellner L, Jethwa A, Stolz T, Slabicki M, Lee K, Sharathchandra A, Benner A, et al. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia. Leukemia. 2015;29(10):2015\u201323.","journal-title":"Leukemia"},{"issue":"12","key":"1268_CR88","doi-asserted-by":"crossref","first-page":"16708","DOI":"10.3390\/ijms131216708","volume":"13","author":"A Baldassarre","year":"2012","unstructured":"Baldassarre A, Masotti A. Long non-coding RNAs and p53 regulation. Int J Mol Sci. 2012;13(12):16708\u201317.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1268_CR89","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12032-017-0959-5","volume":"34","author":"S Chen","year":"2017","unstructured":"Chen S, Liang H, Yang H, Zhou K, Xu L, Liu J, Lai B, Song L, Luo H, Peng J, et al. LincRNa-p21: function and mechanism in cancer. Med Oncol. 2017;34(5):98.","journal-title":"Med Oncol"},{"issue":"8","key":"1268_CR90","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/15476286.2016.1271524","volume":"14","author":"KK Ebbesen","year":"2017","unstructured":"Ebbesen KK, Hansen TB, Kjems J. Insights into circular RNA biology. RNA Biol. 2017;14(8):1035\u201345.","journal-title":"RNA Biol"},{"issue":"3","key":"1268_CR91","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41375-019-0594-6","volume":"34","author":"Z Wu","year":"2020","unstructured":"Wu Z, Sun H, Liu W, Zhu H, Fu J, Yang C, Fan L, Wang L, Liu Y, Xu W, et al. Circ-RPL15: a plasma circular RNA as novel oncogenic driver to promote progression of chronic lymphocytic leukemia. Leukemia. 2020;34(3):919\u201323.","journal-title":"Leukemia"},{"issue":"1","key":"1268_CR92","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2018.06.045","volume":"503","author":"L Xia","year":"2018","unstructured":"Xia L, Wu L, Bao J, Li Q, Chen X, Xia H, Xia R. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607\/FZD3\/Wnt\/beta-catenin pathway. Biochem Biophys Res Commun. 2018;503(1):385\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"1268_CR93","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.18632\/aging.101997","volume":"11","author":"W Wu","year":"2019","unstructured":"Wu W, Wu Z, Xia Y, Qin S, Li Y, Wu J, Liang J, Wang L, Zhu H, Fan L, et al. Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p\/PML axis. Aging. 2019;11(11):3561\u201373.","journal-title":"Aging"},{"key":"1268_CR94","first-page":"2855394","volume":"2022","author":"S Li","year":"2022","unstructured":"Li S, Chen J, Fan Y, Xu X, Xiong M, Qi Y, Wu W, Zhao Y. circZNF91 promotes the malignant phenotype of chronic lymphocytic leukemia cells by targeting the miR-1283\/WEE1 axis. Biomed Res Int. 2022;2022:2855394.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1268_CR95","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40364-022-00423-y","volume":"10","author":"X Zhang","year":"2022","unstructured":"Zhang X, Han Y, Hu X, Wang H, Tian Z, Zhang Y, Wang X. Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model. Biomarker research. 2022;10(1):75.","journal-title":"Biomarker research"},{"key":"1268_CR96","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.omtn.2020.04.017","volume":"20","author":"Z Wu","year":"2020","unstructured":"Wu Z, Sun H, Wang C, Liu W, Liu M, Zhu Y, Xu W, Jin H, Li J. Mitochondrial genome-derived circRNA mc-cox2 functions as an oncogene in chronic lymphocytic leukemia. Molecular therapy Nucleic acids. 2020;20:801\u201311.","journal-title":"Molecular therapy Nucleic acids"},{"key":"1268_CR97","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fmolb.2020.00109","volume":"7","author":"AO de Perez","year":"2020","unstructured":"de Perez AO, Rossi M, Gorospe M. Circular RNAs in blood malignancies. Front Mol Biosci. 2020;7:109.","journal-title":"Front Mol Biosci"},{"key":"1268_CR98","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","volume":"78","author":"CR Clapier","year":"2009","unstructured":"Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem. 2009;78:273\u2013304.","journal-title":"Annu Rev Biochem"},{"issue":"21","key":"1268_CR99","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","volume":"71","author":"B Guan","year":"2011","unstructured":"Guan B, Wang TL, Shih Ie M. ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res. 2011;71(21):6718\u201327.","journal-title":"Cancer Res"},{"issue":"2","key":"1268_CR100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2014-10-604959","volume":"126","author":"D Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez D, Bretones G, Quesada V, Villamor N, Arango JR, L\u00f3pez-Guillermo A, Ramsay AJ, Baumann T, Quir\u00f3s PM, Navarro A, et al. Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia. Blood. 2015;126(2):195\u2013202.","journal-title":"Blood"},{"issue":"1","key":"1268_CR101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1074\/jbc.M114.609156","volume":"290","author":"JC Liu","year":"2015","unstructured":"Liu JC, Ferreira CG, Yusufzai T. Human CHD2 is a chromatin assembly ATPase regulated by its chromo- and DNA-binding domains. J Biol Chem. 2015;290(1):25\u201334.","journal-title":"J Biol Chem"},{"issue":"4","key":"1268_CR102","volume":"49","author":"M Kim","year":"2017","unstructured":"Kim M, Costello J. DNA methylation: an epigenetic mark of cellular memory. Exp Mol Med. 2017;49(4): e322.","journal-title":"Exp Mol Med"},{"issue":"3","key":"1268_CR103","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clml.2012.11.009","volume":"13","author":"A Malik","year":"2013","unstructured":"Malik A, Shoukier M, Garcia-Manero G, Wierda W, Cortes J, Bickel S, Keating MJ, Estrov Z. Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II study. Clin Lymphoma Myeloma Leuk. 2013;13(3):292\u20135.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"1268_CR104","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.leukres.2010.08.001","volume":"35","author":"JA Dubovsky","year":"2011","unstructured":"Dubovsky JA, Wang D, Powers JJ, Berchmans E, Smith MA, Wright KL, Sotomayor EM, Pinilla-Ibarz JA. Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers. Leuk Res. 2011;35(3):394\u2013404.","journal-title":"Leuk Res"},{"issue":"32","key":"1268_CR105","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","volume":"27","author":"AA Lane","year":"2009","unstructured":"Lane AA, Chabner BA. Histone deacetylase inhibitors in cancer therapy. J clin oncol off j Am Soc Clin Oncol. 2009;27(32):5459\u201368.","journal-title":"J clin oncol off j Am Soc Clin Oncol"},{"issue":"3","key":"1268_CR106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nm.2305","volume":"17","author":"M Rodr\u00edguez-Paredes","year":"2011","unstructured":"Rodr\u00edguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med. 2011;17(3):330\u20139.","journal-title":"Nat Med"},{"issue":"2","key":"1268_CR107","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-12-1888","volume":"73","author":"SS Burns","year":"2013","unstructured":"Burns SS, Akhmametyeva EM, Oblinger JL, Bush ML, Huang J, Senner V, Chen CS, Jacob A, Welling DB, Chang LS. Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth. Can Res. 2013;73(2):792\u2013803.","journal-title":"Can Res"},{"issue":"1","key":"1268_CR108","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ijc.25660","volume":"129","author":"S Zhang","year":"2011","unstructured":"Zhang S, Suvannasankha A, Crean CD, White VL, Chen CS, Farag SS. The novel histone deacetylase inhibitor, AR-42, inhibits gp130\/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells. Int J Cancer. 2011;129(1):204\u201313.","journal-title":"Int J Cancer"},{"issue":"6","key":"1268_CR109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010941","volume":"5","author":"DM Lucas","year":"2010","unstructured":"Lucas DM, Alinari L, West DA, Davis ME, Edwards RB, Johnson AJ, Blum KA, Hofmeister CC, Freitas MA, Parthun MR, et al. The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo. PLoS ONE. 2010;5(6): e10941.","journal-title":"PLoS ONE"},{"issue":"10","key":"1268_CR110","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4161\/epi.6.10.17200","volume":"6","author":"A Perez-Perarnau","year":"2011","unstructured":"Perez-Perarnau A, Coll-Mulet L, Rubio-Patino C, Iglesias-Serret D, Cosialls AM, Gonzalez-Girones DM, de Frias M, de Sevilla AF, de la Banda E, Pons G, et al. Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells. Epigenetics. 2011;6(10):1228\u201335.","journal-title":"Epigenetics"},{"issue":"7","key":"1268_CR111","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.leu.2403388","volume":"18","author":"DM Lucas","year":"2004","unstructured":"Lucas DM, Davis ME, Parthun MR, Mone AP, Kitada S, Cunningham KD, Flax EL, Wickham J, Reed JC, Byrd JC, et al. The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells. Leukemia. 2004;18(7):1207\u201314.","journal-title":"Leukemia"},{"issue":"2","key":"1268_CR112","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/blood-2002-12-3794","volume":"102","author":"JL Aron","year":"2003","unstructured":"Aron JL, Parthun MR, Marcucci G, Kitada S, Mone AP, Davis ME, Shen T, Murphy T, Wickham J, Kanakry C, et al. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. Blood. 2003;102(2):652\u20138.","journal-title":"Blood"},{"issue":"4","key":"1268_CR113","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2009.07881.x","volume":"147","author":"KA Blum","year":"2009","unstructured":"Blum KA, Advani A, Fernandez L, Van Der Jagt R, Brandwein J, Kambhampati S, Kassis J, Davis M, Bonfils C, Dubay M, et al. Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia. Br J Haematol. 2009;147(4):507\u201314.","journal-title":"Br J Haematol"},{"issue":"3","key":"1268_CR114","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2004-05-1693","volume":"105","author":"JC Byrd","year":"2005","unstructured":"Byrd JC, Marcucci G, Parthun MR, Xiao JJ, Klisovic RB, Moran M, Lin TS, Liu S, Sklenar AR, Davis ME, et al. A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia. Blood. 2005;105(3):959\u201367.","journal-title":"Blood"},{"issue":"6","key":"1268_CR115","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/1878-0261.12692","volume":"14","author":"F Thomas","year":"2020","unstructured":"Thomas F, Holmes KB, Kreuz S, Hillmen P, Lefevre PF. DAPK3 participates in the mRNA processing of immediate early genes in chronic lymphocytic leukaemia. Mol Oncol. 2020;14(6):1268\u201381.","journal-title":"Mol Oncol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01268-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:13:22Z","timestamp":1732986802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01268-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,16]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1268"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01268-x","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,16]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"54"}}